Acute myeloid leukemia patients with NUP98::NSD1 showing initially poor treatment response can benefit from FLT3 inhibitors and venetoclax as well as HSCT

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of hematology 2023-02, Vol.102 (2), p.473-475
Hauptverfasser:	Sun, Haimin, Yan, Han, Yan, Zeying, Zhu, Yongmei, Yang, Guang, Zhang, Sujiang
Format:	Artikel
Sprache:	eng
Schlagworte:	fms-Like Tyrosine Kinase 3 - genetics Hematology Hematopoietic Stem Cell Transplantation Histone-Lysine N-Methyltransferase Humans Letter to the Editor Leukemia, Myeloid, Acute - drug therapy Leukemia, Myeloid, Acute - genetics Medicine Medicine & Public Health Nuclear Pore Complex Proteins Oncology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!